Stock listing

NASDAQ:FLNA Filana Therapeutics, Inc. Stock

Home listing (NASDAQ) of Filana Therapeutics, Inc.

Follow Filana Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:FLNA

$0.641 USD +0.096 (+17.7%)

Close on Nov 20, 2026

Past year -75.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.590 – $0.653 USDNov 20, 2026
Volume
1.32M sharesNov 20, 2026
Market cap
$30.98M USDAt the close on Nov 20, 2026 · price × 48.31M shares outstanding
52-week range
$0.390 – $3.450 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.95M USDMedian day 336,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Filana Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FLNA · Home$0.641 USD+0.096 (+17.7%)1,320,665$0.590$0.653$0.590$0.545Close on Nov 20, 2026
Frankfurt:PX91€0.498 EUR-0.004 (-0.7%)—€0.498€0.498€0.498€0.501Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FLNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.641+0.096+17.7%$0.590$0.653$0.5901,320,665
$0.545+0.064+13.3%$0.477$0.551$0.469789,294
$0.481+0.011+2.3%$0.465$0.495$0.465542,599
$0.470+0.045+10.6%$0.421$0.484$0.3901,271,311
$0.425-0.023-5.1%$0.460$0.470$0.423315,512
$0.448-0.034-7.1%$0.480$0.480$0.436428,051
$0.4820.0000.0%$0.500$0.510$0.480213,816
$0.482-0.010-2.0%$0.500$0.512$0.476221,294
$0.492+0.040+8.7%$0.461$0.505$0.460556,382
$0.453+0.002+0.4%$0.460$0.470$0.426605,611
$0.451-0.121-21.2%$0.570$0.583$0.4501,258,838
$0.572-0.022-3.8%$0.578$0.596$0.556461,979
$0.594+0.033+5.9%$0.572$0.600$0.560361,033
$0.561-0.061-9.8%$0.630$0.630$0.560544,958
$0.622-0.038-5.8%$0.659$0.659$0.620214,783
$0.660+0.010+1.5%$0.660$0.680$0.650264,400
$0.6500.0000.0%$0.660$0.660$0.630347,000
$0.650+0.040+6.6%$0.620$0.650$0.610295,500
$0.610-0.030-4.7%$0.630$0.640$0.600297,000
$0.640-0.010-1.5%$0.640$0.650$0.620311,100
$0.650-0.010-1.5%$0.660$0.670$0.640250,100
$0.660-0.030-4.3%$0.690$0.710$0.650305,800
$0.690+0.010+1.5%$0.670$0.700$0.670198,400
$0.680-0.020-2.9%$0.710$0.710$0.680256,700
$0.700-0.060-7.9%$0.750$0.760$0.700327,900
$0.760+0.030+4.1%$0.710$0.770$0.700248,500
$0.730-0.010-1.4%$0.730$0.740$0.720253,200
$0.740-0.030-3.9%$0.760$0.770$0.740323,500
$0.770-0.050-6.1%$0.810$0.810$0.760360,400
$0.820+0.010+1.2%$0.820$0.840$0.800407,900
$0.810-0.010-1.2%$0.800$0.820$0.780610,800
$0.820-0.050-5.7%$0.850$0.850$0.790759,200
$0.8700.0000.0%$0.890$0.900$0.830670,000
$0.870-0.060-6.5%$0.920$0.930$0.8701,034,800
$0.930-0.040-4.1%$0.970$1.040$0.9301,691,200
$0.970+0.080+9.0%$1.000$1.030$0.9302,804,700
$0.890-0.030-3.3%$0.930$0.950$0.860769,500
$0.920+0.070+8.2%$0.850$0.940$0.8301,202,500
$0.850+0.100+13.3%$0.730$0.890$0.7202,053,900
$0.750-0.020-2.6%$0.780$0.780$0.740771,900
$0.770-0.100-11.5%$0.850$0.900$0.7402,313,600
$0.870-0.160-15.5%$1.000$1.000$0.8005,466,900
$1.030+0.290+39.2%$0.980$1.300$0.90094,301,500
$0.740+0.010+1.4%$0.740$0.770$0.730336,500
$0.730+0.010+1.4%$0.720$0.730$0.710122,800
$0.720+0.040+5.9%$0.690$0.720$0.680274,500
$0.680-0.020-2.9%$0.690$0.700$0.670379,600
$0.700-0.020-2.8%$0.730$0.730$0.680446,000
$0.720-0.050-6.5%$0.770$0.770$0.710379,300
$0.770-0.040-4.9%$0.810$0.810$0.770309,600
$0.8100.0000.0%$0.800$0.810$0.770303,300
$0.810+0.010+1.3%$0.790$0.810$0.760271,300
$0.800-0.020-2.4%$0.810$0.820$0.750509,500
$0.820-0.010-1.2%$0.820$0.850$0.800285,400
$0.830-0.030-3.5%$0.890$0.890$0.820273,200
$0.8600.0000.0%$0.900$0.900$0.820347,200
$0.860-0.040-4.4%$0.900$0.900$0.850217,000
$0.900-0.030-3.2%$0.920$0.930$0.880139,700
$0.930+0.010+1.1%$0.930$0.930$0.910169,900
$0.9200.0000.0%$0.910$0.940$0.910110,300
$0.920-0.029-3.0%$0.940$0.940$0.92056,800
$0.949+0.019+2.0%$0.919$0.957$0.913110,136
$0.930-0.030-3.1%$0.950$0.951$0.920121,940
$0.960+0.020+2.1%$0.950$0.960$0.940106,200
$0.940-0.030-3.1%$0.950$0.980$0.910167,700

Splits

1 split · NASDAQ:FLNA · every price before a split is adjusted for it

DayRatioWhat
1-for-7Consolidation
Ticker
NASDAQ:FLNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Filana Therapeutics, Inc. news

Filana Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
9 in the last 12 months · 9 in all · newest Nov 11, 2026 · oldest 2026

Where Filana Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FLNA · Home listing · This pageNASDAQUnited StatesUSD
gettex:PX91gettexGermanyEUR
LS Exchange:A2PGL8LS ExchangeGermanyEUR
BOATS:FLNABOATSUnited StatesUSD
Lang & Schwarz:A2PGL8Lang & SchwarzGermanyEUR
Tradegate:PX91TradegateGermanyEUR
BMV:FLNABMVMexicoMXN
Frankfurt:PX91FrankfurtGermanyEUR
Dusseldorf:PX91DusseldorfGermanyEUR
Hamburg:PX91HamburgGermanyEUR
Munich:PX91MunichGermanyEUR
Stuttgart:PX91StuttgartGermanyEUR

Valuation

Price/book 0.5× against a median of 3.3×: 3rd lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$16.01M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.25

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Filana Therapeutics, Inc. · NASDAQ:FLNAUS$30.98M−US$16.01Mn/an/an/a0.5×n/a0.0×1.25
Transcenta Holding Limited · HKEX:6628US$32.41MUS$52.52Mn/a12.4×n/a0.4×−569.5%0.3×n/a
Enimmune Corporation · TPEX:6564US$31.74MUS$26.87Mn/a18.4×n/a10.4×−341.0%0.3×n/a
Molecure SA · GPW:MOCUS$31.66MUS$29.60Mn/an/an/a1.3×n/a0.0×n/a
Sareum Holdings plc · LSE:SARUS$31.03MUS$27.78Mn/an/an/a19.9×n/a0.0×n/a
Isofol Medical AB · OMXSTO:ISOFOLUS$31.03MUS$19.80Mn/an/an/a3.3×n/a0.0×n/a
Caribou Biosciences, Inc. · NASDAQ:CRBUUS$30.71M−US$37.75Mn/a−4.0×n/a0.4×n/a0.3×1.87
Avecho Biotechnology Limited · ASX:AVEUS$30.69MUS$26.46Mn/a32.3×n/a24.3×−356.8%0.1×n/a
Kalaris Therapeutics, Inc. · NASDAQ:KLRSUS$30.47M−US$51.05Mn/an/an/a0.6×n/a0.0×0.47
Pacific Software, Inc. · OTC:PFSFUS$29.86MUS$38.10Mn/an/an/an/an/an/a1.57
NextCure, Inc. · NASDAQ:NXTCUS$29.53MUS$20.81Mn/an/an/a5.4×n/a0.0×1.85
Median of the othersUS$30.87MUS$26.67M15.4×3.3×−356.8%0.0×1.71

Forecasts

1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
6.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.86 · 2 analysts

Team and board

Officers

OfficerRole
Richard J. BarryPresident & Chief Executive Officer
Eric SchoenChief Financial Officer
R. Christopher CookChief Operating and Legal Officer
Angélique BordeySVP, Neuroscience
George ThorntonSr. VP, Technology
Jack MooreSr. VP, Clinical Development
Michael ZamlootSr. VP, Tech. Operations
Joseph HulihanChief Medical Officer
Nancy TeasdaleHead of Regulatory Affairs

Board

DirectorRole
Claude NicaiseIndependent Director, Chairman of the Board
Dawn Carter BirIndependent Director
Jill M. QuigleyDirector
Patrick Scannon MDIndependent Director
Pierre GravierIndependent Director
Richard J. BarryPresident & Chief Executive Officer
Robert AndersonIndependent Director

Events

Next results
Mar 11, 2027 (expected)
QuarterResultsShare move
Q3 2026Nov 5, 2026 · Before open−21.1%
Q2 2026Jul 29, 2026 · Before open−1.1%
Q1 2026May 7, 2026 · Before open−5.6%
Q4 2025Mar 12, 2026−4.8%
Q3 2025Nov 12, 2025 · Before open+4.8%
Q2 2025Aug 14, 2025+2.6%
Q1 2025May 8, 2025+13.5%
Q4 2024Mar 3, 2025 · Before open+3.3%
Q3 2024Nov 7, 2024 · Before open−4.6%
Q2 2024Aug 8, 2024 · Before open−13.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 13, 2024+15.3%
Q4 2023Feb 28, 2024 · Before open−0.3%
Q3 2023Nov 7, 2023 · Before open+4.3%
Q2 2023Aug 3, 2023 · Before open−0.7%
Q1 2023May 1, 2023 · Before open+0.5%
Q4 2022Feb 28, 2023+1.0%
Q3 2022Nov 7, 2022 · Before open−3.3%
Q2 2022Aug 4, 2022 · After close+2.0%
Q1 2022May 5, 2022 · Before open−1.7%
Q4 2021Mar 1, 2022−4.5%

Open Events

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000
Cost of revenue936.0K22.0K58.0K69.0K68.0K58.0K
Gross profit-936.0K-22.0K-58.0K-69.0K-68.0K-58.0K
Research and development26.6M69.6M89.4M68.0M24.8M7.29M6.30M2.97M7.62M9.18M
Selling, general and administrative68.8M71.8M16.5M12.0M8.05M
Operating income-95.4M-141.4M-106.0M-80.0M-32.9M-6.45M-4.96M-6.66M-11.9M-15.0M
Depreciation and amortization903.0K952.0K1.08M804.0K310.0K22.0K58.0K69.0K68.0K58.0K
EBITDA-94.5M-140.5M-104.9M-79.2M-32.6M-6.42M-4.90M-6.59M-11.9M-14.9M
Income before tax-91.0M-24.3M-97.2M-76.2M-32.4M-6.33M-4.63M-6.56M-11.9M-14.8M
Income tax00
Net income-91.0M-24.3M-97.2M-76.2M-32.4M-6.33M-4.63M-6.56M-11.9M-14.8M
Earnings per share, basic-1.88-0.53-2.32-1.90-0.82-0.24-0.27-0.61-1.82-2.28
Earnings per share, diluted-1.88-1.46-2.32-1.90-0.82-0.24-0.27-0.61-1.82-2.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents95.5M128.6M121.1M201.0M233.4M93.5M23.1M19.8M10.5M16.6M
Short-term investments2.10M
Receivables120.0K947.0K962.0K
Current assets97.7M136.5M129.6M211.2M244.5M94.0M23.3M20.0M10.7M19.1M
Property, plant and equipment20.6M21.0M21.9M22.9M20.6M11.0K47.0K87.0K156.0K232.0K
Total assets118.4M157.5M151.7M234.8M266.8M94.3M23.5M20.1M10.8M19.3M
Accounts payable6.40M7.65M10.6M4.02M7.13M911.0K453.0K294.0K424.0K303.0K
Current liabilities43.8M11.8M14.2M7.06M12.5M1.86M1.39M511.0K1.13M665.0K
Total debt139.0K236.0K293.0K90.0K
Total liabilities44.0M11.8M14.2M7.29M12.9M2.10M1.39M511.0K1.13M665.0K
Shareholders' equity74.4M145.7M137.5M227.5M253.9M92.2M22.1M19.6M9.70M18.6M
Shares outstanding48.3M48.2M42.2M41.7M40.0M35.2M21.8M17.2M6.60M6.59M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-32.3M-116.9M-82.0M-77.5M-30.2M-5.38M-2.51M-4.77M-8.24M-12.2M
Capital spending-581.0K-103.0K-414.0K-2.71M-22.2M0-18.0K00-75.0K
Free cash flow-32.8M-117.0M-82.4M-80.2M-52.4M-5.38M-2.53M-4.77M-8.24M-12.3M
Cash from investing-581.0K-103.0K-414.0K-2.71M-22.2M360.0K-18.0K2.10M-2.17M
Cash from financing-239.0K124.5M2.56M47.8M192.3M75.4M5.81M14.1M-284.0K
Share buybacks-60.0K
Change in cash-33.1M7.44M-79.9M-32.4M139.9M70.4M3.27M9.33M-6.14M-14.7M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 20, 2026Insider tradeSEC
4 · Change in ownershipNov 20, 2026Insider tradeSEC
4 · Change in ownershipNov 19, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 12, 2026Insider tradeSEC
8-K · Current reportNov 12, 2026Management or board changeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportNov 5, 2026ResultsSEC
8-K · Current reportOct 20, 2026Current reportSEC
4 · Change in ownershipOct 1, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
8-K · Current reportSep 22, 2026Current reportSEC
8-K · Current reportSep 18, 2026Current reportSEC
10-Q · Quarterly reportJul 29, 2026Quarterly reportSEC
8-K · Current reportJul 29, 2026ResultsSEC
8-K · Current reportJun 15, 2026Management or board changeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
8-K · Current reportApr 28, 2026Management or board changeSEC
10-K · Annual reportMar 12, 2026Annual reportSEC
8-K · Current reportMar 12, 2026ResultsSEC
8-K · Current reportMar 10, 2026Current reportSEC
8-K · Current reportFeb 19, 2026Current reportSEC
8-K · Current reportDec 23, 2025Material contractSEC
8-K/A · Current report, amendedDec 22, 2025Management or board changeSEC
8-K · Current reportDec 18, 2025Current reportSEC
8-K · Current reportDec 17, 2025Management or board changeSEC
EFFECT · Notice that a registration is effectiveDec 8, 2025Other filingsSEC
424B2 · ProspectusDec 5, 2025Offer documentSEC
CORRESP · Letter to the SECDec 3, 2025Other filingsSEC
8-K · Current reportDec 3, 2025Current reportSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
S-3 · Registration statementNov 12, 2025Offer documentSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
8-K · Current reportOct 24, 2025Current reportSEC
4 · Change in ownershipOct 22, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 22, 2025Insider tradeSEC
8-K · Current reportOct 22, 2025Management or board changeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipSep 23, 2025Insider tradeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
8-K · Current reportSep 8, 2025Current reportSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025ResultsSEC
8-K · Current reportAug 4, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 16, 2025Big-stake noticeSEC
4 · Change in ownershipJul 16, 2025Insider tradeSEC
8-K · Current reportJun 30, 2025Current reportSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
8-K · Current reportMay 27, 2025Management or board changeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
8-K · Current reportApr 21, 2025Management or board changeSEC
ARS · Annual report to shareholdersApr 14, 2025Annual reportSEC
DEF 14A · Proxy statementApr 14, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 3, 2025Meeting noticeSEC
8-K · Current reportMar 25, 2025Current reportSEC
8-K · Current reportMar 11, 2025Management or board changeSEC
10-K · Annual reportMar 3, 2025Annual reportSEC
8-K · Current reportMar 3, 2025ResultsSEC
8-K · Current reportFeb 27, 2025Material contractSEC
8-K · Current reportJan 7, 2025ResultsSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 26, 2024Big-stake noticeSEC
8-K · Current reportNov 25, 2024Current reportSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 20, 2024Insider tradeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
8-K · Current reportOct 8, 2024Current reportSEC
4 · Change in ownershipOct 1, 2024Insider tradeSEC
8-K/A · Current report, amendedOct 1, 2024Management or board changeSEC
8-K · Current reportSep 27, 2024Current reportSEC
8-K · Current reportSep 17, 2024Current reportSEC
4 · Change in ownershipSep 9, 2024Insider tradeSEC
4 · Change in ownershipSep 9, 2024Insider tradeSEC
4 · Change in ownershipSep 9, 2024Insider tradeSEC
8-K · Current reportSep 9, 2024Management or board changeSEC
SCHEDULE 13G · Big-stake noticeAug 21, 2024Big-stake noticeSEC
8-K/A · Current report, amendedAug 9, 2024ResultsSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
8-K · Current reportJul 22, 2024Current reportSEC
8-K · Current reportJul 18, 2024Current reportSEC
8-K · Current reportJul 17, 2024Management or board changeSEC
8-K · Current reportJul 1, 2024Current reportSEC
8-K · Current reportMay 22, 2024Management or board changeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
4 · Change in ownershipMay 16, 2024Insider tradeSEC
8-K · Current reportMay 13, 2024Meeting outcomeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportMay 10, 2024ResultsSEC
8-K · Current reportMay 8, 2024Current reportSEC
25-NSEMay 3, 2024Other filingsSEC
8-K · Current reportMay 1, 2024Current reportSEC
4 · Change in ownershipApr 30, 2024Insider tradeSEC
4 · Change in ownershipApr 25, 2024Insider tradeSEC
4 · Change in ownershipApr 22, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
8-K · Current reportApr 15, 2024Current reportSEC
DEF 14A · Proxy statementMar 26, 2024Meeting noticeSEC
ARS · Annual report to shareholdersMar 22, 2024Annual reportSEC
10-K · Annual reportFeb 28, 2024Annual reportSEC
8-K · Current reportFeb 28, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
8-K · Current reportFeb 7, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 1, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 26, 2024Big-stake noticeSEC
CERT · Exchange's certificate of listingJan 3, 2024Other filingsSEC
424B2 · ProspectusJan 3, 2024Offer documentSEC
8-A12B · Registration of shares for listing on an exchangeJan 3, 2024Other filingsSEC
8-K · Current reportJan 3, 2024Material contractSEC
8-A12G · Registration of a class of sharesJan 2, 2024Other filingsSEC
8-K · Current reportDec 12, 2023Current reportSEC
8-K · Current reportDec 11, 2023Management or board changeSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 8, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 7, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 7, 2023Insider tradeSEC
10-Q · Quarterly reportNov 7, 2023Quarterly reportSEC
8-K · Current reportNov 7, 2023ResultsSEC
4 · Change in ownershipOct 4, 2023Insider tradeSEC
4 · Change in ownershipOct 4, 2023Insider tradeSEC
4 · Change in ownershipOct 4, 2023Insider tradeSEC
4 · Change in ownershipOct 4, 2023Insider tradeSEC
8-K · Current reportSep 13, 2023Current reportSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 23, 2023Insider tradeSEC
UPLOAD · Letter from the SECAug 14, 2023Other filingsSEC
CORRESP · Letter to the SECAug 10, 2023Other filingsSEC
10-Q · Quarterly reportAug 3, 2023Quarterly reportSEC
8-K · Current reportAug 3, 2023ResultsSEC
UPLOAD · Letter from the SECJul 28, 2023Other filingsSEC
8-K · Current reportJul 5, 2023Current reportSEC
4 · Change in ownershipJun 12, 2023Insider tradeSEC
4 · Change in ownershipMay 25, 2023Insider tradeSEC
4 · Change in ownershipMay 10, 2023Insider tradeSEC
4 · Change in ownershipMay 8, 2023Insider tradeSEC
4 · Change in ownershipMay 8, 2023Insider tradeSEC
4 · Change in ownershipMay 8, 2023Insider tradeSEC
4 · Change in ownershipMay 8, 2023Insider tradeSEC
4 · Change in ownershipMay 8, 2023Insider tradeSEC
8-K · Current reportMay 8, 2023Meeting outcomeSEC
4 · Change in ownershipMay 2, 2023Insider tradeSEC
8-K · Current reportMay 1, 2023Material contractSEC
424B5 · ProspectusMay 1, 2023Offer documentSEC
S-3ASR · Registration statementMay 1, 2023Offer documentSEC
10-Q · Quarterly reportMay 1, 2023Quarterly reportSEC
8-K · Current reportMay 1, 2023ResultsSEC
DEF 14A · Proxy statementMar 27, 2023Meeting noticeSEC
8-K · Current reportMar 16, 2023Management or board changeSEC
ARS · Annual report to shareholdersMar 16, 2023Annual reportSEC
PRE 14A · Preliminary proxy statementMar 16, 2023Meeting noticeSEC
8-K · Current reportMar 10, 2023Current reportSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
10-K · Annual reportFeb 28, 2023Annual reportSEC
8-K · Current reportFeb 28, 2023ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 8, 2023Big-stake noticeSEC
5 · Annual statement of ownershipFeb 7, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 1, 2023Big-stake noticeSEC
8-K · Current reportJan 24, 2023Current reportSEC
5 · Annual statement of ownershipJan 3, 2023Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Filana Therapeutics, Inc.’s releases

Common shares
48,307,896
Fully diluted
48,307,896

Fully diluted

LineShares
Common shares48,307,896

Share count over time

CountShares
Nov 22, 202648,307,896

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard2.41M5.0%US$2.13MSep 30, 2026
BlackRock1.45M3.0%US$1.28MSep 30, 2026
Marshall Wace, LLP1.16M2.4%US$1.03MSep 30, 2026
Geode Capital612K1.3%US$543KSep 30, 2026
GMT Capital Corp450K0.93%US$399KSep 30, 2026
Gsa Capital Partners LLP436K0.90%US$386KSep 30, 2026
Two Sigma423K0.88%US$375KSep 30, 2026
Squarepoint Ops LLC376K0.78%US$333KSep 30, 2026
Acadian Asset Management LLC317K0.66%US$280KSep 30, 2026
Renaissance Technologies222K0.46%US$197KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
State Street209K0.43%US$185KSep 30, 2026
Stifel Financial Corp200K0.41%US$177KSep 30, 2026
Group One Trading LLC197K0.41%US$175KSep 30, 2026
Susquehanna196K0.41%US$174KSep 30, 2026
Federated Hermes, Inc.131K0.27%US$116KSep 30, 2026
Northern Trust114K0.24%US$101KSep 30, 2026
Hrt Financial LP72,7090.15%US$64,000Sep 30, 2026
Goldman Sachs62,6010.13%US$55,464Sep 30, 2026
UBS59,6900.12%US$52,885Sep 30, 2026
Simplex Trading, LLC55,6990.12%US$49,349Sep 30, 2026
Verition Fund Management LLC46,8700.10%US$41,527Sep 30, 2026
XTX Topco Ltd46,3710.10%US$41,085Sep 30, 2026
T. Rowe Price40,8600.08%US$37,000Sep 30, 2026
LPL Financial LLC39,6430.08%US$35,123Sep 30, 2026
Mgo One Seven LLC33,3390.07%US$29,538Sep 30, 2026
JPMorgan31,0470.06%US$28,709Sep 30, 2026
Bank of America30,8710.06%US$27,352Sep 30, 2026
Osaic Holdings, Inc.28,0390.06%US$24,959Sep 30, 2026
Engineers Gate Manager LP24,4470.05%US$21,660Sep 30, 2026
BNY20,2840.04%US$17,972Sep 30, 2026
Jane Street20,2750.04%US$17,964Sep 30, 2026
Apollon Wealth Management, LLC16,4140.03%US$14,543Sep 30, 2026
Marex Group Ltd15,5000.03%US$13,733Sep 30, 2026
Cetera Investment Advisers15,2420.03%US$13,504Sep 30, 2026
Mayport, LLC13,4000.03%US$11,872Sep 30, 2026
Morgan Stanley9,3610.02%US$8,294Sep 30, 2026
Jones Financial Companies Lllp8,2120.02%US$6,143Sep 30, 2026
Fidelity7,2320.01%US$6,408Sep 30, 2026
Wells Fargo5,8170.01%US$5,154Sep 30, 2026
Federation des caisses Desjardins du Quebec4,695<0.01%US$4,160Sep 30, 2026
Activest Wealth Management4,001<0.01%US$3,545Sep 30, 2026
SBI Securities Co., Ltd.2,986<0.01%US$2,646Sep 30, 2026
Optiver Holding B.V.2,884<0.01%US$2,555Sep 30, 2026
Walleye Trading LLC2,258<0.01%US$2,001Sep 30, 2026
Signature Equity Partners, LLC2,000<0.01%US$1,772Sep 30, 2026
NewEdge Advisors, LLC1,550<0.01%US$1,373Sep 30, 2026
National Bank Of Canada1,510<0.01%US$1,318Sep 30, 2026
Smartleaf Asset Management LLC1,369<0.01%US$1,266Sep 30, 2026
Nuveen1,119<0.01%US$2,025Sep 30, 2026
MidFirst Bank1,000<0.01%US$886Sep 30, 2026

This page holds 50 of 76 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.37M2.8%US$1.63MJun 30, 2026
Vanguard Extended Market Index Fund564K1.2%US$671KJun 30, 2026
Fidelity Extended Market Index Fund283K0.59%US$436KMay 31, 2026
iShares Micro-Cap ETF149K0.31%US$177KJun 30, 2026
Vanguard Health Care Index Fund132K0.27%US$203KMay 31, 2026
Fidelity Total Market Index Fund81,4610.17%US$125KMay 31, 2026
Fidelity Series Total Market Index Fund72,4740.15%US$112KMay 31, 2026
Goldman Sachs Absolute Return Tracker Fund42,6050.09%US$50,700Jun 30, 2026
Fidelity Nasdaq Composite Index Fund39,9530.08%US$61,528May 31, 2026
Invesco NASDAQ Future Gen 200 ETF33,7010.07%US$51,900May 31, 2026
All 20 holders
HolderSharesOf the companyValueAs of
Fidelity ZERO Total Market Index Fund31,0560.06%US$31,367Jul 31, 2026
Vanguard Balanced Index Fund24,5250.05%US$29,185Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund20,7300.04%US$24,669Jun 30, 2026
Fidelity ZERO Extended Market Index Fund16,0780.03%US$16,239Jul 31, 2026
Blackstone Alternative Multi-Strategy Fund10,6000.02%US$12,614Jun 30, 2026
Fidelity Flex Small Cap Index Fund10,0490.02%US$10,149Jul 31, 2026
1290 VT Micro Cap Portfolio10,0190.02%US$11,923Jun 30, 2026
VIP Extended Market Index Portfolio3,495<0.01%US$4,159Jun 30, 2026
VIP Total Market Index Portfolio1,237<0.01%US$1,472Jun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND259<0.01%US$262Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Barry Richard
Director, Officer: President & CEO
Buy100,000USD 0.92US$92,000Sep 30, 2026
Barry Richard
Director, Officer: President & CEO
Buy206,813USD 0.90US$186KSep 29, 2026
Barry Richard
Director, Officer: President & CEO
Buy93,091USD 0.84US$78,196Sep 28, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Saira Ramasastry
Other companies: Sensei Biotherapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 15, 2026); Mirum Pharmaceuticals, Inc. (Director · Since at least Jun 2, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Vir Biotechnology, Inc. (Director · Since at least Oct 10, 2019); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Repros Therapeutics (Director · Mar 25, 2013 – Jan 29, 2018 · Past); Sangamo Therapeutics, Inc. (Director · Jun 21, 2012 – Feb 25, 2022 · Past)
Director · Feb 11, 2013 – Dec 13, 2019 · Past
Peter S Roddy
Other companies: Cytokinetics, Incorporated (SVP Finance & CAO · Feb 8, 2018 – Feb 27, 2018 · Past); Aspira Women's Health Inc. (Director · Feb 18, 2010 – Mar 17, 2016 · Past)
Chief Financial Officer · May 1, 2010 – Apr 8, 2016 · Past
Claude Nicaise
Other companies: Sarepta Therapeutics, Inc. (Director · Since at least Jun 5, 2026)
Independent Director, Chairman of the Board · Since at least Nov 5, 2026
Richard J. Barry
Other companies: Sarepta Therapeutics, Inc. (Director · Since at least Dec 31, 2020)
President & Chief Executive Officer · Since at least Jun 11, 2021
Angélique BordeySVP, Neuroscience · Since at least Oct 28, 2026
Dawn Carter BirIndependent Director · Since at least Nov 5, 2026
Eric SchoenChief Financial Officer · Since at least Oct 28, 2026
Freda NassifChief Business Officer · Nov 18, 2024 – Apr 17, 2025 · Past
George ThorntonSr. VP, Technology · Since at least Nov 5, 2026
Jack MooreSr. VP, Clinical Development · Since at least Nov 4, 2026
All 24 people
PersonSeat
James William KupiecChief Medical Officer · Oct 3, 2023 – Nov 29, 2024 · Past
Jaren LandenChief Clinical Dev. Officer · Nov 18, 2024 – Nov 18, 2024 · Past
Jill M. QuigleyDirector · Since at least Nov 11, 2026
Joseph HulihanChief Medical Officer · Since at least Nov 5, 2026
Michael ZamlootSr. VP, Tech. Operations · Since at least Nov 5, 2026
Nadav FriedmannChief Medical Officer, Director · May 27, 2022 – Dec 31, 2022 · Past
Nancy TeasdaleHead of Regulatory Affairs · Since at least Nov 5, 2026
Patrick J Md Phd ScannonDirector · Since at least May 4, 2023
Patrick Scannon MDIndependent Director · Since at least Nov 4, 2026
Pierre GravierIndependent Director · Since at least Nov 5, 2026
R. Christopher CookChief Operating and Legal Officer · Since at least Nov 5, 2026
Robert AndersonIndependent Director · Since at least Nov 5, 2026
Robert Christopher CookChief Operating & Legal Office · Since at least Oct 28, 2022
Robert Eugene Anderson JrDirector · Since at least May 23, 2025

Open People

Log in to ask 6ix AI your own questions about Filana Therapeutics, Inc.